BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 28670985)

  • 1. [Changes in diagnostic criteria of thrombotic microangiopathy after stem cell transplantation].
    Horváth O; Prohászka Z; Kállay K; Kassa C; Stréhn A; Csordás K; Sinkó J; Kriván G
    Orv Hetil; 2017 Jul; 158(27):1043-1050. PubMed ID: 28670985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Increase in Complement Terminal Pathway Activation Marker sC5b-9 Is Predictive for the Development of Thrombotic Microangiopathy after Stem Cell Transplantation.
    Horváth O; Kállay K; Csuka D; Mező B; Sinkovits G; Kassa C; Stréhn A; Csordás K; Sinkó J; Prohászka Z; Kriván G
    Biol Blood Marrow Transplant; 2018 May; 24(5):989-996. PubMed ID: 29339271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation.
    Jodele S; Fukuda T; Mizuno K; Vinks AA; Laskin BL; Goebel J; Dixon BP; Chima RS; Hirsch R; Teusink A; Lazear D; Lane A; Myers KC; Dandoy CE; Davies SM
    Biol Blood Marrow Transplant; 2016 Feb; 22(2):307-315. PubMed ID: 26456258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy.
    Elsallabi O; Bhatt VR; Dhakal P; Foster KW; Tendulkar KK
    Clin Appl Thromb Hemost; 2016 Jan; 22(1):12-20. PubMed ID: 26239316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy?
    Dhakal P; Bhatt VR
    Bone Marrow Transplant; 2017 Mar; 52(3):352-356. PubMed ID: 27775697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy.
    Vasu S; Wu H; Satoskar A; Puto M; Roddy J; Blum W; Klisovic R; Andritsos L; Hofmeister C; Benson DM; Efebera Y; Jaglowski S; Penza S; Cohen D; Devine S; Cataland S
    Bone Marrow Transplant; 2016 Sep; 51(9):1241-4. PubMed ID: 27064689
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation.
    Qi J; Wang J; Chen J; Su J; Tang Y; Wu X; Ma X; Chen F; Ruan C; Zheng XL; Wu D; Han Y
    Ann Hematol; 2017 Nov; 96(11):1849-1855. PubMed ID: 28801815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Eculizumab in Patients With Allogeneic Stem Cell Transplant-Associated Thrombotic Microangiopathy: A Study From the SFGM-TC.
    de Fontbrune FS; Galambrun C; Sirvent A; Huynh A; Faguer S; Nguyen S; Bay JO; Neven B; Moussi J; Simon L; Xhaard A; Resche-Riggon M; O'Meara A; Fremeaux-Bacchi V; Veyradier A; Socié G; Coppo P; de Latour RP
    Transplantation; 2015 Sep; 99(9):1953-9. PubMed ID: 25651309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Eculizumab in Thrombotic Microangiopathy Associated with Hematopoietic Stem Cell Transplantation.
    Demircioglu S; Dogan A; Demir C
    J Coll Physicians Surg Pak; 2021 Nov; 31(11):1359-1361. PubMed ID: 34689499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic microangiopathy following haematopoietic stem cell transplant.
    Seaby EG; Gilbert RD
    Pediatr Nephrol; 2018 Sep; 33(9):1489-1500. PubMed ID: 28993886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults.
    Jodele S; Davies SM; Lane A; Khoury J; Dandoy C; Goebel J; Myers K; Grimley M; Bleesing J; El-Bietar J; Wallace G; Chima RS; Paff Z; Laskin BL
    Blood; 2014 Jul; 124(4):645-53. PubMed ID: 24876561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic Microangiopathy in Cancer.
    Weitz IC
    Semin Thromb Hemost; 2019 Jun; 45(4):348-353. PubMed ID: 31041804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
    Jodele S; Fukuda T; Vinks A; Mizuno K; Laskin BL; Goebel J; Dixon BP; Teusink A; Pluthero FG; Lu L; Licht C; Davies SM
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):518-25. PubMed ID: 24370861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of eculizumab in autologous hematopoietic stem cell transplantation-associated thrombotic microangiopathy in two adults.
    Alhomoud M; Williams A; Magro C; Van Besien K; Vesole DH; Laurence J
    Leuk Lymphoma; 2022 Feb; 63(2):473-477. PubMed ID: 34668824
    [No Abstract]   [Full Text] [Related]  

  • 15. Emerging Concepts in Hematopoietic Stem Cell Transplantation-Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments.
    Wanchoo R; Bayer RL; Bassil C; Jhaveri KD
    Am J Kidney Dis; 2018 Dec; 72(6):857-865. PubMed ID: 30146419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cell transplantation-associated thrombotic microangiopathy accompanied by renal arteriolar C4d deposition.
    Sakamoto K; Imamura T; Osone S; Nishimura A; Nishida M; Ishida H; Hosoi H
    Pediatr Transplant; 2015 Jun; 19(4):E97-100. PubMed ID: 25735190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of intestinal graft-versus-host disease and thrombotic microangiopathy after allogeneic stem cell transplantation.
    Yamada-Fujiwara M; Miyamura K; Fujiwara T; Tohmiya Y; Endo K; Onishi Y; Ishizawa K; Kameoka J; Ito M; Harigae H
    Tohoku J Exp Med; 2012 May; 227(1):31-7. PubMed ID: 22531159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy.
    Peffault de Latour R; Xhaard A; Fremeaux-Bacchi V; Coppo P; Fischer AM; Helley D; Socié G
    Br J Haematol; 2013 Apr; 161(2):279-80. PubMed ID: 23294015
    [No Abstract]   [Full Text] [Related]  

  • 19. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
    Laskin BL; Goebel J; Davies SM; Jodele S
    Blood; 2011 Aug; 118(6):1452-62. PubMed ID: 21596850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eculizumab and thrombotic microangiopathy after hematopoietic stem cell transplantation: A report on its efficacy and safety in two pediatric patients.
    Genere L; Bacchetta J; Bertrand Y; Javouhey E; Cheikh N; Sellier-Leclerc AL
    Arch Pediatr; 2018 Nov; 25(8):485-488. PubMed ID: 30340942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.